A clinical investigation of the efficacy of splinting by a trained family member as compared to standard treatment on maintaining knee movement following knee bleeds in patients with hemophilia.
Not Applicable
- Conditions
- Health Condition 1: null- HemophiliaHemarthrosis and Knee flexion deformities
- Registration Number
- CTRI/2014/12/005330
- Lead Sponsor
- Hemophilia Federation of India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Person with Hemophilia between the ages of 7 years and 60 years
Person with Hemophilia enrolled with the Bangalore Chapter of the Hemophilia Society
Exclusion Criteria
i. Person with Hemophilia having acute bleeds to their knee during the last 3 months
ii. Person with Hemophilia having fixed deformities to their knees >15°
iii. Person with Hemophilia with decreased ROM (with <15°) due to a cause other than bleeding into the joint, eg quadriceps contracture, bony deformity etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are implicated in hemarthrosis-induced knee flexion deformities in hemophilia patients?
How does family-administered thermoplastic splinting compare to standard physiotherapy in preserving knee range of motion post-hemorrhage?
Which biomarkers correlate with improved joint mobility outcomes in hemophilia-associated hemarthrosis trials?
What adverse events are associated with low-temperature thermoplastic splinting for acute knee bleeds in hemophilia?
Are there combination therapies involving splinting and factor replacement that enhance joint function recovery in hemophilia A/B?